Details of Drug

Details of Drug

 Drug General Information (ID: D1745)
  Drug Name
Bazedoxifene
  Drug Type Small molecule
  Drug Synonymous
Brilence; Conbriza; Viviant; Bazedoxifene acetate; TSE-424; WAY-140424; WAY-TES 424
    Click to Show/Hide
  Disease Class LD24: Skeletal anomaly
  Therapeutic Class Hormone Modulators
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C30H34N2O3
  InChI 1S/C30H34N2O3/c1-22-28-20-26(34)12-15-29(28)32(30(22)24-8-10-25(33)11-9-24)21-23-6-13-27(14-7-23)35-19-18-31-16-4-2-3-5-17-31/h6-15,20,33-34H,2-5,16-19,21H2,1H3
  InChIKey UCJGJABZCDBEDK-UHFFFAOYSA-N
  Canonical SMILES CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O
  External Link
Pubchem ID 154257
CAS Number CAS 198481-32-2
CHEBI ID CHEBI:135947
TTD ID D0JY8T
INTEDE ID DR0177

Drug-Drug Interaction Network
  Sunburst Graph
AM004  Affected intra/extra-hepatic metabolism
BM019  UGT inhibition
  Relation Graph
 Full list of drugs interacting with Bazedoxifene
      Affected intra/extra-hepatic metabolism
   UGT inhibition Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1528
 
Tafamidis
 
C14H7Cl2NO3
 
11001318 
Moderate    Inter Info   
[1], [2], [3]
References
1 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
2 Product Information. Vyndaqel (tafamidis). Pfizer U.S. Pharmaceuticals Group, New York, NY.
3 Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".